Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years as the country tackles a recent increase of infections.
"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding, "its safety profile is also consistent with the known safety profile in the adult population."
The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.
US and Iran signal a peace deal is close
Qatar rejects media report on energy production decisions
Trump says Iran war deal close as Strait of Hormuz tensions linger
Victims' families mark Air India crash anniversary with prayers and tributes
Ebola outbreak spreads to crowded displacement camp in Congo
Fire breaks out at New Zealand's Wellington airport, disrupting flights
Ukraine and Russia trade overnight drone strikes, officials say
UN says Taliban arrest 30 women for violating hijab rules in Afghanistan
